|
|||||
|
|
Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009 |
|
| Authors: | Boyd M A Siangphoe U Ruxrungtham K Duncombe C J Stek M Lange J M A Cooper D A Phanuphak P |
| Affiliation: | The HIV Netherlands Australia Thailand Research Collaboration, the Thai Red Cross AIDS Research Centre, Bangkok, Thailand. mark.boyd@fmc.sa.gov.au |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |